<DOC>
	<DOCNO>NCT02297256</DOCNO>
	<brief_summary>This study single-center , prospective randomize clinical study intend compare evaluate efficacy subject treat bone marrow aspirate concentrate ( BMAC ) allograft iliac crest bone graft ( ICBG ) posterior lumbar/lumbosacral spinal fusion .</brief_summary>
	<brief_title>Prospective Study Thoracolumbar Spinal Fusion Graft</brief_title>
	<detailed_description>Subjects candidate posterior lumbar lumbosacral spinal fusion without anterior interbody support screen inclusion study . Participants enrol randomize either BMAC + allograft ICBG group . An enrollment ratio two BMAC + allograft one ICBG subject ( 2:1 ) total 40 subject enrol study also account fail screening subject . The study determine compare difference fusion rate health relate quality life parameter 6 week , 3 month , 6 month , 1 year , 2 year postoperatively .</detailed_description>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Must 18 year old old Scheduled elective posterior spinal fusion thoracolumbar spine lumbar spine without anterior interbody support Failed least 6 week conservative care ODI v2.1 score &gt; 30 % No contraindication BMAC ( per manufacturer ) Signed consent form Spondylolisthesis grade â‰¥ 3 Pagets disease , osteomalacia , metabolic bone disease Use medication interfere bone heal ( chronic steroid ) Patient unlikely comply postop schedule physician Recent history chemical dependency Participation investigational device trial ( ) within past 30 day Active malignancy Pregnancy planning become pregnant Direct involvement execution protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>